Clinical Trial

Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 300 mg clopidogrel were assessed through NIHSS, mRS, and possible adverse effects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-08.
Trial Details
NCT Number NCT06591338
Lead Sponsor Kafrelsheikh University
Conditions Ischemic Stroke
Enrollment 900 participants
Start Date 2024-09-01
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-10-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-05